June 1, 2023 at 6:11 am
#4885
Nick HargraveKeymaster
https://www.londonstockexchange.com/news-article/AVCT/avacta-acquires-coris-bioconcept/15980091
We are a bit disappointed to see the company allocate cash to lower margin diagnostic acquisitions given the potential value in therapeutics. Shareholders will likely want to hear a very strong rationale at the upcoming AGM (to be announced)
